JANX News and Press, Janux Therapeutics Inc. From 12/02/25

2025-12-02 05:01:07 ET More on related stocks: Janux Therapeutics, Inc. (JANX) Shareholder/Analyst Call Transcript Credo Technology Group Holding Ltd (CRDO) Q2 2026 Earnings Call Transcript MongoDB, Inc. (MDB) Q3 2026 Earnings Call Transcript Janux reports po...

2025-12-02 04:07:39 ET More on Janux Therapeutics Janux Therapeutics, Inc. (JANX) Shareholder/Analyst Call Transcript Janux Therapeutics: The Rumor Mill Spins Up Again Janux Therapeutics gains amid renewed takevover speculation Janux is a new Buy at Truist ah...

2025-12-01 23:13:24 ET Janux Therapeutics, Inc. (JANX) Shareholder/Analyst Call December 1, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Janux Therapeutics, Inc. (JANX) Shareholder/Analyst Call Transcript

Phase 1 data demonstrates durable responses and rPFS coupled with a manageable safety profile rPFS of 7.9-8.9 months in heavily pre-treated mCRPC patients Preliminary results are encouraging with deep PSA reductions and a promising CRS profile in taxane-naïve Phase 1b expansi...

The virtual event will take place on Monday, December 1, 2025, at 4:30 PM ET Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activ...

2025-11-06 18:01:50 ET More on Janux Therapeutics Janux Therapeutics: The Rumor Mill Spins Up Again Janux Therapeutics gains amid renewed takevover speculation Janux is a new Buy at Truist ahead of catalyst rich H2 Seeking Alpha’s Quant Rating on Janux...

Enrollment ongoing for JANX007 and JANX008 Updates on JANX007 and JANX008 expected in the fourth quarter of 2025 $989.0 million in cash, cash equivalents, and short-term investments at end of third quarter 2025 Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clini...

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

2025-10-29 09:55:43 ET Topline Summary Read the full article on Seeking Alpha For further details see: Janux Therapeutics: The Rumor Mill Spins Up Again

2025-10-28 10:11:44 ET More on Janux Therapeutics Janux: A High-Risk/High-Reward Bet On Oncology And Autoimmune Therapies Backed By $1B In Cash Janux is a new Buy at Truist ahead of catalyst rich H2 Piper Sandler initiates coverage of oncology companies Seeki...